Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118293426 | 11829342 | 6 | F | 2000 | 20160714 | 20151211 | 20160721 | EXP | PHHY2015VE162936 | NOVARTIS | 42.22 | YR | M | Y | 0.00000 | 20160721 | MD | VE | VE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118293426 | 11829342 | 1 | PS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | 10187 | 20 | MG | QD | |||||||
| 118293426 | 11829342 | 2 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | 10187 | ||||||||||||
| 118293426 | 11829342 | 3 | SS | RITALIN SR | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | SLOW RELEASE TABLET | QD | ||||||
| 118293426 | 11829342 | 4 | SS | RITALIN SR | METHYLPHENIDATE HYDROCHLORIDE | 1 | 0 | SLOW RELEASE TABLET | |||||||||||
| 118293426 | 11829342 | 5 | SS | RITALIN SR | METHYLPHENIDATE HYDROCHLORIDE | 1 | 0 | SLOW RELEASE TABLET | |||||||||||
| 118293426 | 11829342 | 6 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 118293426 | 11829342 | 7 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 118293426 | 11829342 | 8 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118293426 | 11829342 | 1 | Disturbance in attention |
| 118293426 | 11829342 | 2 | Depression |
| 118293426 | 11829342 | 3 | Affective disorder |
| 118293426 | 11829342 | 4 | Attention deficit/hyperactivity disorder |
| 118293426 | 11829342 | 5 | Depression |
| 118293426 | 11829342 | 6 | Depression |
| 118293426 | 11829342 | 7 | Depression |
| 118293426 | 11829342 | 8 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118293426 | 11829342 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118293426 | 11829342 | Anxiety | |
| 118293426 | 11829342 | Apathy | |
| 118293426 | 11829342 | Cognitive disorder | |
| 118293426 | 11829342 | Communication disorder | |
| 118293426 | 11829342 | Depressed mood | |
| 118293426 | 11829342 | Depression | |
| 118293426 | 11829342 | Disturbance in attention | |
| 118293426 | 11829342 | Malaise | |
| 118293426 | 11829342 | Paralysis | |
| 118293426 | 11829342 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118293426 | 11829342 | 1 | 2000 | 20151208 | 0 | |
| 118293426 | 11829342 | 8 | 1996 | 0 |